2024 United States Breast Cancer Outlook
Breast cancer predictions for this year.
Invasive female breast cancer has been rising by nearly 0.6% per year since the mid-2000s, according to a recent report by the American Cancer Society. This is partly due to an overall increase in body weight in women and a change in birth patterns – women are waiting longer to have children and having fewer. The increase in cases is also slightly higher in women under 50 than those over 50 (1% per year vs. 0.5% per year) judging by data collected from 2012 to 2019.
Although breast cancer diagnoses are happening earlier, there has been a sharp decline in cases. The death rate peaked in 1989 and has declined by 42% as of 2021. This can be attributed to early detection, improved treatment and greater breast cancer awareness.
The following information was gathered from the American Cancer Society’s Cancer Facts and Figures: 2024.
How Financial Toxicity Screening Can Be Incorporated Into Everyday Healthcare in America
November 15th 2024Breast cancer treatment settings prove to be a good opportunity to talk about financial toxicity. These conversations can also happen in generalized healthcare, according to Laila Gharzai, M.D., LLM, from the Department of Radiation Oncology at Northwestern University.
Read More
Breast Cancer Patients Desire Early, Frequent Financial Screening
November 11th 2024Current financial screening procedures in the United States may need to change, according to recent research done by Laila Gharzai, M.D., LLM, from the Department of Radiation Oncology at Northwestern University.
Read More
Patient Advocacy Groups and Caretaker Diversity in Metastatic Breast Cancer Research
October 22nd 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes in Metastatic Breast Cancer Care Delivery, shares the reasons why she chose to study metastatic breast cancer patients.
Read More
Differences in Defining 'Clinically Meaningful' in Metastatic Breast Cancer Care
October 4th 2024Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute, explains the importance of the term “clinically meaningful” and shares some of the ways it can be defined.
Read More
